ZAGAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zagam, and what generic alternatives are available?
Zagam is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in ZAGAM is sparfloxacin. Additional details are available on the sparfloxacin profile page.
Summary for ZAGAM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Patent Applications: | 4,782 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ZAGAM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ZAGAM
US Patents and Regulatory Information for ZAGAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | ZAGAM | sparfloxacin | TABLET;ORAL | 020677-001 | Dec 19, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZAGAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | ZAGAM | sparfloxacin | TABLET;ORAL | 020677-001 | Dec 19, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZAGAM
See the table below for patents covering ZAGAM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2029786 | ⤷ Try a Trial | |
Latvia | 5501 | Hinolina atvasinajumu ai to farmaceitiski pienemama estera vai farmaceitiski pienemamas hinolina atvasinajuma vai estera sals iegusanas metode | ⤷ Try a Trial |
European Patent Office | 0375658 | Dérivés de quinoléine et procédé de leur préparation. (Quinoline derivatives and processes for preparation thereof.) | ⤷ Try a Trial |
Denmark | 170774 | ⤷ Try a Trial | |
U.S.S.R. | 1519529 | CПOCOБ ПOЛУЧEHИЯ ПPOИЗBOДHOГO XИHOЛИHA, EГO ФAPMAЦEBTИЧECKИ ПPИEMЛEMOГO CЛOЖHOГO ЭФИPA ИЛИ ФAPMAЦEBTИЧECKИ ПPИEMЛEMOЙ COЛИ ПPOИЗBOДHOГO XИHOЛИHA ИЛИ CЛOЖHOГO ЭФИPA (METHOD OF PRODUCING QUINOLINE DERIVATIVES, ITS PHARMACEUTICALLY ACCEPTABLE ESTER OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS) | ⤷ Try a Trial |
Denmark | 514586 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZAGAM
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0375658 | C300014 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ORBIFLOXACIN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZUURADDITIEZOUT; REGISTRATION NO/DATE: NL 9652 - NL 9654 20000208 |
0375658 | SPC/GB98/036 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ORBIFLOXACIN; REGISTERED: UK 00201/4035 19980608; UK 00201/4036 19980608; UK 00201/4037 19980608 |
0375658 | 25/2000 | Austria | ⤷ Try a Trial | PRODUCT NAME: ORBIFLOXACIN; NAT. REGISTRATION NO/DATE: 8-00439, 8-00440, 8-00438 20000225; FIRST REGISTRATION: GB VM 00201/4035 - 00201/4037 19980608 |
0375658 | 2000C/020 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ORBIFLOXACINE; NAT. REGISTRATION NO/DATE: 282 IS 58 F3 20000228; FIRST REGISTRATION: GB VM00201/4036 19980608 |
0221463 | SPC/GB95/012 | United Kingdom | ⤷ Try a Trial | SPC/GB95/012: 20061024, EXPIRES: 20090106 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |